[Effect of estrogen-gestagen combination therapy in advanced breast carcinoma with special reference to pulmonary metastases].
D001859:Bone Neoplasms / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy*; D002277:Carcinoma / Q000188:drug therapy; D004357:Drug Synergism; D004958:Estradiol / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008593:Menopause; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010997:Pleural Neoplasms / Q000188:drug therapy; D011374:Progesterone / Q000009:adverse effects / Q000627:therapeutic use*; D011379:Prognosis; D012878:Skin Neoplasms / Q000188:drug therapy; D013927:Thrombosis / Q000209:etiology
D011374:Progesterone; D004958:Estradiol
Die Wirkung einer Ostrogen-Gestagen-Kombinationstherapie beim fortgeschrittenen Mammakarzinom mit besonderer Berücksichtigung der Lungenmetastasen.